Results 91 to 100 of about 74,576 (156)

Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Nonrandomized Clinical Trial.

JAMA Oncol
Zhang M, Fu S, Feng J, Hong R, Wei G, Zhao H, Zhao M, Xu H, Cui J, Huang S, Wu X, Liu L, Sun J, Wu W, Zhu Y, He J, Zhao Y, Cai Z, Zheng W, Ye X, Shi J, Luo Y, Wang D, Chang AH, Hu Y, Huang H.   +25 more
europepmc   +1 more source

A phase 2 trial of a "sandwich" strategy: Sequential CD22/CD19 chimeric antigen receptor T-cells therapy combined with autologous hematopoietic stem cell transplantation in patients with Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia. [PDF]

Cancer
Qian CS, Wang ZH, Li Z, Yao Z, Gong WJ, Wu YJ, Zhou HX, Xu MZ, Qiu Y, Xu SZ, Tan KW, Liu FT, Huang SM, Cao HY, Dai HP, Wu DP, Xue SL.   +16 more
europepmc   +1 more source

A comprehensive prognostic and immune analysis of <i>LAPTM4B</i> in pan-cancer and Philadelphia chromosome-positive acute lymphoblastic leukemia. [PDF]

Front Immunol
Zhou H, Yi Y, He W, Zheng L, Hu Y, Niu T.   +5 more
europepmc   +1 more source

How I treat Philadelphia chromosome-like acute lymphoblastic leukemia in children, adolescents, and young adults.

Blood
Tran TH, Tasian SK.
europepmc   +1 more source

Clinical Characteristics, Prognostic Factors, and Thrombotic and Bleeding Outcomes in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Single-Center Cohort Study in Thailand. [PDF]

Cureus
Suttantapidok S, Owattanapanich W.
europepmc   +1 more source

MRD in Philadelphia Chromosome-Positive ALL: Methodologies and Clinical Implications. [PDF]

Curr Hematol Malig Rep
Tran V, Salafian K, Michaels K, Jones C, Reed D, Keng M, El Chaer F.   +6 more
europepmc   +1 more source

Development and validation of an interpretable machine learning model for predicting Philadelphia chromosome-positive acute lymphoblastic leukaemia using clinical and laboratory parameters: a single-centre retrospective study. [PDF]

BMJ Open
Yang W, Liu J, Gou Y, Huang X, Chen M, Huang D, Wu S, Zhang J, Zhang C, Liu S, Peng X, Zhang X.   +11 more
europepmc   +1 more source

Efficacy and safety of olverembatinib as maintenance therapy after allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia. [PDF]

Ann Hematol
Kong J, Zheng FM, Yan CH, Wang JZ, Fu HX, Wang ZD, Suo P, Hu GH, Lv M, Chen H, Mo XD, Xu LP, Zhang XH, Huang XJ, Wang Y.   +14 more
europepmc   +1 more source

Nilotinib Versus Imatinib in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph+ CML): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs). [PDF]

Cureus
Zafar F, Poombal F, Ashraf L, Shivakumar D, Wankhade D, Winayak R, Ali Malik GM, Mahapatra SS, G C S, Huynh T, Mylavarapu M.   +10 more
europepmc   +1 more source

Characterization of Asciminib-Resistant Philadelphia Chromosome-Positive Cells. [PDF]

World J Oncol
Okabe S, Moriyama M, Gotoh A.
europepmc   +1 more source